Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes

Total article views   HTML views PDF downloads Totals
10,556 Dovepress* 9,369+ 1,505 10,874
PubMed Central* 1,187 422 1,609
Totals 10,556 1,927 12,483
*Since 7 September 2018

View citations on PubMed Central and Google Scholar